Enhanced cardiac device management utilizing the random EGM: A neglected feature of remote monitoring

Published:September 29, 2015DOI:
      Remote monitoring (RM) of cardiac implantable devices is rapidly becoming the standard of care for implantable cardiac device follow-up.


      CRT (cardiac resynchronization therapy), ECG (electrocardiogram), EGM (electrogram), ICD (implantable cardioveter-defibrillator), RV (right ventricle/ventricular), LV (left ventricle/ventricular), rEGM (random electrogram), RV (right ventricle/ventricular), VT (ventricular tachycardia)


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Mabo P.
        • Victor F.
        • Bazin P.
        • Ahres S.
        • Babuty D.
        • Da Costa A.
        • Binet D.
        • Daubert J.-C.
        COMPAS Trial Investigators. A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial).
        Eur Heart J. 2012; 33: 1105-1111
        • Varma N.
        • Epstein A.E.
        • Irimpen A.
        • Schweikert R.
        • Love C.
        TRUST Investigators. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial.
        Circulation. 2010; 122: 325-332
        • Crossley G.H.
        • Boyle A.
        • Vitense H.
        • Chang Y.
        • Mead R.H.
        CONNECT Investigators. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts.
        J Am Coll Cardiol. 2011; 57: 1181-1189
        • Hindricks G.
        • Taborsky M.
        • Glikson M.
        • et al.
        Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial.
        Lancet. 2014; 384: 583-590
        • Varma N.
        • Michalski J.
        • Epstein A.E.
        • Schweikert R.
        Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) trial.
        Circ Arrhythm Electrophysiol. 2010; 3: 428-436
        • Guédon-Moreau L.
        • Kouakam C.
        • Klug D.
        • Marquié C.
        • Brigadeau F.
        • Boulé S.
        • Blangy H.
        • Lacroix D.
        • Clémenty J.
        • Sadoul N.
        • Kacet S.
        Decreased delivery of inappropriate shocks achieved by remote monitoring of ICD: a substudy of the ECOST trial.
        J Cardiovasc Electrophysiol. 2014; 25: 763-770
        • Ellenbogen K.A.
        • Gunderson B.D.
        • Stromberg K.D.
        • Swerdlow C.D.
        Performance of Lead Integrity Alert to assist in the clinical diagnosis of implantable cardioverter defibrillator lead failures: analysis of different implantable cardioverter defibrillator leads.
        Circ Arrhythm Electrophysiol. 2013; 6: 1169-1177
        • Slotwiner D.
        • Varma N.
        • Akar J.G.
        • et al.
        HRS Expert Consensus Statement on Remote Interrogation and Monitoring for Cardiovascular Electronic Implantable Devices.
        Heart Rhythm. 2015; 12: e69-e100
        • Lazarus A.
        Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database.
        Pacing Clin Electrophysiol. 2007; 30: S2-S12